Azitra Inc (AZTR) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Azitra Inc

NYSE MKT | AZTR

0.28

USD

-0.033 (-10.38%)

AT CLOSE (AS OF Apr 17, 2025)

$4.3M

MARKET CAP

P/E Ratio

-71.1

EPS

$8.8

52 Week High

$0.23

52 Week Low

LIFE SCIENCES

Sector

AZTR Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

AZTR Technicals

Tags:

AZTR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$7.5M
Total Revenue	$7.5M
Cost Of Revenue	-
Costof Goods And Services Sold	-
Operating Income	-$11B
Selling General And Administrative	$6.3B
Research And Development	$4.7B
Operating Expenses	$11B
Investment Income Net	-
Net Interest Income	$110K
Interest Income	$123K
Interest Expense	$12K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$448K
Income Before Tax	-$9B
Income Tax Expense	-$9M
Interest And Debt Expense	-
Net Income From Continuing Operations	-$9M
Comprehensive Income Net Of Tax	-
Ebit	-$11B
Ebitda	-$11B
Net Income	-$9M

Revenue & Profitability

Earnings Performance

AZTR Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$7.4B
Total Current Assets	$5.2B
Cash And Cash Equivalents At Carrying Value	$4.6B
Cash And Short Term Investments	$4.6B
Inventory	-
Current Net Receivables	-
Total Non Current Assets	$2.1B
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$246K
Intangible Assets Excluding Goodwill	$246K
Goodwill	$246M
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$673M
Other Non Current Assets	-
Total Liabilities	$1.7B
Total Current Liabilities	$1.4B
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$272M
Total Non Current Liabilities	$285M
Capital Lease Obligations	$556K
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$556M
Other Current Liabilities	$1.1B
Other Non Current Liabilities	-
Total Shareholder Equity	$5.7B
Treasury Stock	-
Retained Earnings	-$58M
Common Stock	-
Common Stock Shares Outstanding	$3.8M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$10B
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$448K
Capital Expenditures	$379K
Change In Receivables	-
Change In Inventory	-
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$13M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$9B

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$7.5M
Total Revenue	$7.5M
Cost Of Revenue	-
Costof Goods And Services Sold	-
Operating Income	-$11B
Selling General And Administrative	$6.3B
Research And Development	$4.7B
Operating Expenses	$11B
Investment Income Net	-
Net Interest Income	$110K
Interest Income	$123K
Interest Expense	$12K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$448K
Income Before Tax	-$9B
Income Tax Expense	-$9M
Interest And Debt Expense	-
Net Income From Continuing Operations	-$9M
Comprehensive Income Net Of Tax	-
Ebit	-$11B
Ebitda	-$11B
Net Income	-$9M

AZTR Profile

Azitra Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. The company is headquartered in Branford, Connecticut.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.00	9.68%	-	409,386,220
STSS	$0.03	20.75%	$522.68K	391,799,240
NVDA	$101.49	-2.87%	$2.48T	292,517,465
HTZ	$8.24	44.31%	$2.54B	266,908,117
FMTO	$0.02	-35.81%	$2.41M	198,396,141

Symbol	Price	Change %	Market Cap	Volume
LLY	$839.96	14.30%	$754.27B	10,853,385
PG	$170.63	2.55%	$400.10B	7,227,061
JNJ	$157.47	2.31%	$379.48B	10,981,067
ABBV	$172.99	0.76%	$306.02B	8,998,056
NVO	$58.08	-7.63%	$282.79B	32,220,629

Symbol	Price	Change %	Market Cap	Volume
MSGM	$2.75	145.54%	$8.75M	36,058,545
SXTC	$2.16	118.42%	$29.73M	51,508,885
ADGM	$1.78	92.81%	$54.65M	114,733,769
PNBK	$3.28	73.55%	$13.04M	1,511,087
RTC	$0.37	72.09%	$10.86M	187,018,434

Symbol	Price	Change %	Market Cap	Volume
JEWL	$0.00	-90.83%	$2.78M	470,134
LXEH	$6.84	-70.25%	$26.82M	1,373,607
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644

Quick Links

AZTR $0.29 (-10.38%) Quote details